Efgartigimod efficacious, safe for primary immune thrombocytopenia
The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic or persistent primary ...
Read moreDetails
Tag: efficacious
The Earth News is an independent English-language daily published Website from all around the World News
